These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
545 related articles for article (PubMed ID: 30663726)
21. Anti-metastatic Effects of Cationic KT2 Peptide (a Lysine/Tryptophan-rich Peptide) on Human Melanoma A375.S2 Cells. Maraming P; Klaynongsruang S; Boonsiri P; Peng SF; Daduang S; Rungsa P; Tavichakorntrakool R; Chung JG; Daduang J In Vivo; 2021; 35(1):215-227. PubMed ID: 33402468 [TBL] [Abstract][Full Text] [Related]
22. Luteolin, an aryl hydrocarbon receptor ligand, suppresses tumor metastasis in vitro and in vivo. Feng J; Zheng T; Hou Z; Lv C; Xue A; Han T; Han B; Sun X; Wei Y Oncol Rep; 2020 Nov; 44(5):2231-2240. PubMed ID: 33000272 [TBL] [Abstract][Full Text] [Related]
23. Comparative studies to evaluate relative in vitro potency of luteolin in inducing cell cycle arrest and apoptosis in HaCaT and A375 cells. George VC; Naveen Kumar DR; Suresh PK; Kumar S; Kumar RA Asian Pac J Cancer Prev; 2013; 14(2):631-7. PubMed ID: 23621210 [TBL] [Abstract][Full Text] [Related]
24. Osthole exhibits anti-cancer property in rat glioma cells through inhibiting PI3K/Akt and MAPK signaling pathways. Ding D; Wei S; Song Y; Li L; Du G; Zhan H; Cao Y Cell Physiol Biochem; 2013; 32(6):1751-60. PubMed ID: 24356539 [TBL] [Abstract][Full Text] [Related]
25. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742 [TBL] [Abstract][Full Text] [Related]
26. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways. Pan J; Cai X; Zheng X; Zhu X; Feng J; Wang X Tissue Cell; 2022 Apr; 75():101740. PubMed ID: 35101688 [TBL] [Abstract][Full Text] [Related]
27. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma Chen YF; Wu S; Li X; Chen M; Liao HF Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596 [TBL] [Abstract][Full Text] [Related]
28. Schizandrin A exerts anti-tumor effects on A375 cells by down-regulating H19. Bi Y; Fu Y; Wang S; Chen X; Cai X Braz J Med Biol Res; 2019; 52(10):e8385. PubMed ID: 31618367 [TBL] [Abstract][Full Text] [Related]
29. Luteolin Reduces Aqueous Extract PM2.5-induced Metastatic Activity in H460 Lung Cancer Cells. Lin HW; Shen TJ; Yang NC; Wang M; Hsieh WC; Chuang CJ; Lai CY; Chang YY Int J Med Sci; 2022; 19(10):1502-1509. PubMed ID: 36185331 [TBL] [Abstract][Full Text] [Related]
30. Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. Chen PS; Shih YW; Huang HC; Cheng HW PLoS One; 2011; 6(5):e20164. PubMed ID: 21629786 [TBL] [Abstract][Full Text] [Related]
31. Promotion of apoptosis in melanoma cells by taxifolin through the PI3K/AKT signaling pathway: Screening of natural products using WGCNA and CMAP platforms. Wang Y; Chen SJ; Ma T; Long Q; Chen L; Xu KX; Cao Y Int Immunopharmacol; 2024 Sep; 138():112517. PubMed ID: 38924866 [TBL] [Abstract][Full Text] [Related]
32. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway. Ni H; Ji D; Huang Z; Li J Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294 [TBL] [Abstract][Full Text] [Related]
33. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200 [TBL] [Abstract][Full Text] [Related]
34. ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway. Zhang Y; Liang J; Cao N; Gao J; Xie Y; Zhou S; Tang X BMC Cancer; 2022 Jul; 22(1):778. PubMed ID: 35840921 [TBL] [Abstract][Full Text] [Related]
36. EnDuo, a novel derivative of Endostar, inhibits the migration of colon cancer cells, suppresses matrix metalloproteinase-2/9 expression and impedes AKT/ERK activation. Idiiatullina E; Al-Azab M; Walana W; Pavlov V; Liu B Biomed Pharmacother; 2021 Feb; 134():111136. PubMed ID: 33341042 [TBL] [Abstract][Full Text] [Related]
37. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways. Chun J; Kim YS Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902 [TBL] [Abstract][Full Text] [Related]
38. S-petasin induces apoptosis and inhibits cell migration through activation of p53 pathway signaling in melanoma B16F10 cells and A375 cells. Guo L; Kang JS; Kang NJ; Choi YW Arch Biochem Biophys; 2020 Oct; 692():108519. PubMed ID: 32763235 [TBL] [Abstract][Full Text] [Related]
39. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells. Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861 [TBL] [Abstract][Full Text] [Related]
40. A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathways. Deng W; Sui H; Wang Q; He N; Duan C; Han L; Li Q; Lu M; Lv S BMC Complement Altern Med; 2013 Mar; 13():65. PubMed ID: 23506655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]